BCM
PBYI icon

Bridgeway Capital Management’s Puma Biotechnology PBYI Stock Holding History

Bridgeway Capital Management’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.42M Buy
791,616
+16,275
+2% +$119K 0.11% 255
2026
Q1 		$4.95M Buy
775,341
+1,856
+0.2% +$12K 0.1% 274
2025
Q4 		$4.6M Buy
773,485
+339,924
+78% +$1.81M 0.1% 272
2025
Q3 		$2.3M Buy
433,561
+230,771
+114% +$979K 0.05% 507
2025
Q2 		$696K Buy
202,790
+121,690
+150% +$388K 0.02% 715
2025
Q1 		$240K Sell
81,100
-24,100
-23% -$75.4K 0.01% 882
2024
Q4 		$321K Buy
105,200
+800
+0.8% +$2.33K 0.01% 908
2024
Q3 		$266K Sell
104,400
-35,000
-25% -$106K 0.01% 1003
2024
Q2 		$454K Hold
139,400
– – 0.01% 881
2024
Q1 		$739K Buy
139,400
+15,000
+12% +$80.8K 0.02% 826
2023
Q4 		$539K Sell
124,400
-24,000
-16% -$79.5K 0.01% 923
2023
Q3 		$390K Hold
148,400
– – 0.01% 949
2023
Q2 		$524K Hold
148,400
– – 0.01% 882
2023
Q1 		$459K Buy
148,400
+28,300
+24% +$107K 0.01% 910
2022
Q4 		$508K Sell
120,100
-6,000
-5% -$20.7K 0.01% 877
2022
Q3 		$299K Hold
126,100
– – 0.01% 1040
2022
Q2 		$359K Sell
126,100
-50,000
-28% -$124K 0.01% 954
2022
Q1 		$507K Sell
176,100
-64,613
-27% -$167K 0.01% 929
2021
Q4 		$732K Buy
+240,713
New +$1.04M 0.01% 870

Other funds holding PBYI

ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bridgeway Capital Management's PBYI Position: Q2 2026 in Review

Bridgeway Capital Management increased its Puma Biotechnology (PBYI) stake by 2.1% in Q2 2026, buying an estimated $119K and bringing the position to 791,616 shares worth $6.42M. The position accounts for 0.11% of the portfolio, ranked #255.

Bridgeway Capital Management first reported a position in PBYI in Q4 2021 and has held it in 19 quarters since. 161 funds tracked by Wall St. Rank hold PBYI as of Q2 2026.

  • Bridgeway Capital Management held 791,616 shares of Puma Biotechnology worth $6.42M as of Q2 2026.
  • Bridgeway Capital Management bought 16,275 Puma Biotechnology shares in Q2 2026, an estimated $119K.
  • Puma Biotechnology made up 0.11% of Bridgeway Capital Management's portfolio in Q2 2026, its #255 holding.
  • Bridgeway Capital Management first reported a position in Puma Biotechnology in Q4 2021 and has held it in 19 quarters since.
  • 161 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2026.

Based on Bridgeway Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.